Study helps lay the foundations for a future of “smart” tissue therapeutics that can be scaled to a patient’s needs.

MIT-backed startup launches no-code AI platform enabling biologists to design proteins, accelerating drug discovery, reducing ...

OpenProtein.AI is helping biologists stay on the cutting edge of AI with a no-code platform for protein engineering.

From IIT Kanpur to MIT, Professor Mriganka Sur's journey spans electrical engineering to pioneering neuroscience, driven by a ...

MAHARASHTRA, INDIA, April 1, 2026 / EINPresswire.com / — MIT Art, Design and Technology University (MIT-ADT) has been awarded accreditation by the Data Science Council of America (DASCA), marking a ...

Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But ...

The MCP flaw reveals a systemic AI security gap, exposing enterprise systems to supply chain attacks and forcing a shift ...

Pune (Maharashtra) [India], April 14: JISA Softech Private Limited, a leading cybersecurity and technology solutions provider, has entered into a strategic Memorandum of Understanding (MoU) with MIT ...

In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary ...

Although AI coding tools have stoked fears that the technology will replace software engineers, jobs in the field are growing ...

It allows developers to treat text as a fluid substance that can be recalculated every single frame without dropping a beat.

Breaking away from conventional robots that perform only predefined functions once fabricated, researchers have developed a ...